Vacunas contra el COVID-19 para personas con inmunodepresión moderada o grave

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Up-to-date Information

Up-to-Date Info: To find the latest CDC information on this topic go to: https://www.cdc.gov/coronavirus/2019-nCoV/index.html

Vacunas contra el COVID-19 para personas con inmunodepresión moderada o grave

2 de sep. del 2022
By National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

[PDF-675.11 KB]

Details Supporting Files You May Also Like

Details:

Alternative Title:

COVID-19 vaccines for people who are moderately or severely immunocompromised [Spanish]
Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
Description:

COVID-19 vaccines for people who are moderately or severely immunocompromised [Spanish]

Actualizado el 2 de sep. del 2022
Content Notes:

Preadolescentes, adolescentes y adultos con inmunodepresión moderada o grave -- Niños de 6 meses a 11 años de edad con inmunodepresión moderada o grave -- ¿Cómo saber si una persona tiene compromiso inmunitario moderado o grave? -- Personas que se vacunaron fuera de los Estados Unidos -- Preguntas frecuentes.
Subjects:

[+]

COVID-19 COVID-19 Vaccines Immunization, Secondary Immunocompromised Host Vaccination
Document Type:

Webpage
Name as Subject:

Janssen COVID-19 vaccine ; Moderna COVID-19 vaccine ; Novavax vaccine ; Pfizer-BioNTech COVID-19 vaccine

Janssen COVID-19 vaccine ; Moderna COVID-19 vaccine ; Novavax vaccine ; Pfizer-BioNTech COVID-19 vaccine Less -
Collection(s):

Stephen B. Thacker CDC Library collection
Main Document Checksum:

[+]

urn:sha256:ba858e42f4020ef2800bcca2e1847a7d340367ec3bad22f6249c3000dfa8d23b
Download URL:

https://stacks.cdc.gov/view/cdc/120867/cdc_120867_DS1.pdf
File Type:

immuno.html

htm

More +